TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $17.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $17.00M, a 466.67% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $3.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $5.00M, a 0.00% change from fiscal 2016.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $5.00M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $17.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $3.00M 10-K · filed 2026-02-03 | |
| 2017-12-31 | $5.00M 10-K · filed 2018-02-12 | |
| 2016-12-31 | $5.00M 10-K · filed 2019-02-19 | |
| 2015-12-31 | $120.00M 20-F · filed 2017-02-15 | |
| 2014-12-31 | $74.00M 20-F · filed 2017-02-15 | |
| 2013-12-31 | $19.00M 20-F · filed 2016-02-11 | |
| 2012-12-31 | $6.00M 20-F · filed 2015-02-09 | |
| 2011-12-31 | $35.00M 20-F · filed 2014-02-10 | |
| 2010-12-31 | $222.00M 20-F · filed 2013-02-12 | |
| 2009-12-31 | $161.00M 20-F · filed 2012-02-17 | |
| 2008-12-31 | $227.00M 20-F · filed 2011-02-15 |